KronosMD Inc CEO to attend the Annual Roth Investor 13-03-2023, 22:36

Crusoe Closes $600M in Series D Round at $2.8 Billion Valuation to Power AI 12-12-2024, 20:00

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51